CIK: 0001609251 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Dec 8, 2020
Total Value ($000): $314,096 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS | 82,258 | $46,046 | 14.7% | $342.96 | +75.8% | COM | 75886F107 |
| — | ALEXION PHARMACEUTICALS INC | 396,575 | $45,380 | 14.4% | $97.60 | — | COM | 015351109 |
| UTHR | UNITED THERAPEUTICS CORP | 426,215 | $43,048 | 13.7% | $121.76 | -9.9% | COM | 91307C102 |
| BIIB | BIOGEN INC | 137,163 | $38,910 | 12.4% | $311.05 | -10.3% | COM | 09062X103 |
| ENTA | ENANTA PHARMACEUTICALS INC | 825,329 | $37,784 | 12.0% | $44.30 | +9.4% | COM | 29251M106 |
| — | TARO PHARMACEUTICAL INDUS | 537,378 | $29,475 | 9.4% | $78.25 | — | COM | M8737E108 |
| MCK | MCKESSON CORP | 186,030 | $27,705 | 8.8% | $138.18 | +6.2% | COM | 58155Q103 |
| ALKS | ALKERMES PLC | 1,572,395 | $26,055 | 8.3% | $18.61 | -2.4% | COM | G01767105 |
| — | SURGALIGN HOLDINGS INC | 6,251,208 | $11,315 | 3.6% | $1.81 | — | COM | 86882C105 |
| — | INVACARE CORP | 880,920 | $6,625 | 2.1% | $12.03 | — | COM | 461203101 |
| ANAB | ANAPTYSBIO INC | 118,858 | $1,753 | 0.6% | $23.65 | -23.7% | COM | 032724106 |